Back to News
Market Impact: 0.25

Adagene Inc. - Depositary Receipt (ADAG) Price Target Increased by 11.46% to 11.57

Analyst EstimatesAnalyst InsightsCompany FundamentalsHealthcare & Biotech

Average one-year price target for Adagene (NasdaqGM: ADAG) was revised up to $11.57 from $10.38, an 11.46% increase versus the prior estimate dated March 25, 2026. The update reflects a more optimistic consensus among analysts but, absent additional company news, is likely to produce only modest near-term upside rather than a material re-rating.

Analysis

Average one-year price target for Adagene (NasdaqGM: ADAG) was revised up to $11.57 from $10.38, an 11.46% increase versus the prior estimate dated March 25, 2026. The update reflects a more optimistic consensus among analysts but, absent additional company news, is likely to produce only modest near-term upside rather than a material re-rating.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.25